Big Pharma Needs Luck

Deepak Singh at bbgm ponders an article he read in the Financial Times that pairs drug discovery and serendipity. There is a role for serendipity in drug discovery, but the declining productivity of the pharma industry is not necessarily due to lazy scientists who can't innovate, he says. Systems biology is tough -- and managing and understanding all the data from these experiments is no easy task.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.